S64 Type 1 Diabetes: Pathogenesis, Prevention, and Pumps

Program: Symposia
Clinical/Translational Session
Saturday, March 7, 2015: 4:30 PM-6:00 PM
Room 29 (San Diego Convention Center)
**This session is eligible for CME credit**

Supported by the Leona M. and Harry B. Helmsley Charitable Trust

Robert Alan Vigersky, MD, Walter Reed National Military Med Ctr, Washington, DC

RAV: Principal Investigator, Dexcom, Advisory Group Member, Medtronic Minimed.
4:30 PM
Marian Rewers, MD, PhD, Barbara Davis Center for Childhood Diabetes, University of Colorado School of Medicine, Aurora, CO
Nothing to Disclose: MR
5:00 PM
Kevan C Herold, MD, Yale University, Norwalk, CT
Nothing to Disclose: KCH
5:30 PM
Moshe Phillip, MD, Institute for Endocrinology and Diabetes, National Center of Childhood Diabetes, Schneider Children's Medical Center of Israel, Petah Tiqwa, Israel
Disclosure: MP: Medical Advisory Board Member, Astra Zeneca, Medical Advisory Board Member, Bristol-Myers Squibb, Study Investigator, Bristol-Myers Squibb, Medical Advisory Board Member, Eli Lilly & Company, Study Investigator, Eli Lilly & Company, Speaker, Medtronic Minimed, Medical Advisory Board Member, Medtronic Minimed, Study Investigator, Medtronic Minimed, Speaker, Novo Nordisk, Study Investigator, Novo Nordisk, Study Investigator, Merck & Co., Study Investigator, Roche Diagnostics, Study Investigator, Pfizer, Inc., Study Investigator, Sanofi, Medical Advisory Board Member, Sanofi, Speaker, Sanofi, Consultant, Andromeda Biotech, Board Member, CGM3 Ltd, Board Member, DreaMed-Diabetes Ltd, Chairman, NG Solutions Ltd.
See more of: Symposia